grant

ENPP1 regulation of mammalian bone mass

Organization YALE UNIVERSITYLocation NEW HAVEN, UNITED STATESPosted 1 Jun 2022Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY202621+ years oldAdolescentAdolescent YouthAdultAdult HumanAgingAnimal ModelAnimal Models and Related StudiesAutomobile DrivingBioavailabilityBiochemicalBiologicalBiological AgentBiological AvailabilityBiological MarkersBiological ProductsBlood PlasmaBody TissuesBone DiseasesBone GrowthBone MatrixBone MineralizationCalcifiedCalcitriolCatalysisCell BodyCell Communication and SignalingCell SignalingCellsChronic Kidney FailureChronic Renal DiseaseChronic Renal FailureClinicCulturing, in vitro Vertebrate, PrimaryDNA mutationDataDevelopmentDietDiseaseDisorderENPP1 proteinEarly-onset osteoporosisEngineeringEnzyme GeneEnzymesExhibitsExperimental DesignsFamilial hypophosphatemic bone diseaseFractureGene TranscriptionGeneralized GrowthGeneticGenetic ChangeGenetic TranscriptionGenetic TransductionGenetic defectGenetic mutationGoalsGrowthHereditaryHistoryHumanHypophosphatemic RicketsInheritedIntracellular Communication and SignalingInvestigationKidneyKidney Urinary SystemLigamentsMammaliaMammalsMedicalMiceMice MammalsMineralsModern ManMolecularMorbidityMurineMusMutationNational Institutes of HealthOrganOsteoporosisPC-1 glycoproteinPathway interactionsPatient AgentsPatientsPhenotypePhosphatesPhysiologic AvailabilityPhysiologic OssificationPhysiologic calcificationPhysiological OssificationPlasmaPlasma SerumPopulationPrimary Cell CulturesProtein Replacement TherapyProteomicsPublic HealthPublicationsRNA ExpressionRecording of previous eventsRegulationRegulatory PathwayReportingResearchReticuloendothelial System, Serum, PlasmaRiskScientific PublicationSignal PathwaySignal TransductionSignal Transduction PathwaySignal Transduction SystemsSignalingSignaling Factor Proto-OncogeneSignaling Pathway GeneSignaling ProteinSkeletonSupplementationSurvival RateTendon structureTendonsTherapeuticTherapeutic AgentsTissue GrowthTissuesTranscriptionTransgenic MiceUnited States National Institutes of HealthVitamin D-Resistant RicketsX linked hypophosphatemia in ricketsX-Linked Hypophosphatemic RicketsX-linked hypophosphatemiaadulthoodarterial calcification of infancyautosomebench bed sidebench bedsidebench to bed sidebench to bedsidebench to clinicbench to clinical practicebio-markersbiologicbiologic markerbiological signal transductionbiologicsbiomarkerbiopharmaceuticalbiotherapeutic agentbonebone disorderbone fracturebone fragilitybone lossbone masscalcificationcandidate identificationchronic kidney diseaseconventional therapyconventional treatmentdesigndesigningdevelopmentaldietsdrivingearly onsetecto-nucleotide pyrophosphatase phosphodiesterase 1ectonucleotide pyrophosphatase phosphodiesterase 1enzyme replacement therapyenzyme replacement treatmentexperimentexperimental researchexperimental studyexperimentsfamilial hypophosphatemia in ricketsfracture riskgenome mutationhistorieshypophosphatemia in ricketsin vivoinhibitorinorganic phosphatejuvenilejuvenile humanmineralizationmodel of animalmortalitymouse modelmurine modelnormal ossificationnovelnucleotide pyrophosphatase-alkaline phosphodiesterase Iontogenyossificationpathwayplasma cell membrane glycoprotein PC-1posterior longitudinal ligament calcificationposterior longitudinal ligament ossificationrenalresponseskeletalskeletal diseaseskeletal disorderskeletonssoft tissuesuccesstranslational study
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Inactivating
including

Ligament

early-onset

mutations in human ENPP1 results in aberrant soft tissue and skeletal mineralization disorders,

Autosomal Recessive Hypophosphatemic Rickets (ARHR2) Ossification of the Posterior Longitudinal

(OPLL), and Generalized Arterial Calcification of Infancy (GACI) in homozygous deficiency, and

osteoporosis…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
ENPP1 regulation of mammalian bone mass — YALE UNIVERSITY | UNITED STATES | Jun 2022 | Dev Procure